, Volume 25, Issue 4, pp 251–264 | Cite as

Associations between HL-A histocompatibility antigens and non-malignant diseases

  • Lars P. Ryder
  • Lillian Staub Nielsen
  • Arne Svejgaard


Data on associations between antigens of the major human histocompatibility system, HL-A, and various non-malignant diseases have been collected from the literature available at the beginning of April, 1974. Combined estimates of relative risks of all diseases studied were calculated for the antigens showing the strongest associations. Definite associations between HL-A antigens and disease exist for the following conditions: ankylosing spondylitis, Reiter's disease, reactive arthritis, acute anterior uveitis with W27, psoriasis vulgaris with HL-A13 and 17, coeliac disease, dermatitis herpetiformis, auto-immune aggressive hepatitis, myasthenia gravis with HL-A8; insulin-dependent diabetes with HL-A8 and W15, and multiple sclerosis with HL-A7. Probable associations were found between psoriatic arthritis and W27, and Grave's disease and HL-A8. The relative risks are almost invariably above one (indicating susceptibility) and for the definite associations they vary from 1.4 (multiple sclerosis in HL-A7 positives) to 120.9 (ankylosing spondylitis in W27-positives).


Multiple Sclerosis Psoriasis Uveitis Spondylitis Psoriatic Arthritis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Aho, K., Ahvonen, P., Lassus, A., Sievers, K., Tiilikainen, A.: HL-A antigen 27 and reactive arthritis. Lancet 1973 II, 157CrossRefGoogle Scholar
  2. 2.
    Albert, E. D., Harms, K., Wank, R., Steinbauer-Rosenthal, I., Scholz, S.: Segregation analysis of HL-A antigens and haplotypes in 50 families of patients with coeliac disease. Transplant Proc. 5, 1785–1789 (1973)PubMedGoogle Scholar
  3. 3.
    Arnason, B. G. W., Fuller, T. C., Lehrich, J. R., Winn, H. J.: Leukocyte antigens (HL-A) in multiple sclerosis. Transpl. abstracts. IV internat. congr. transl. soc. 1972Google Scholar
  4. 4.
    Arnett, F. C.: HL-A antigens in systemic lupus erythematosus. Arthr. and Rheum. 15, 428 (1972)Google Scholar
  5. 5.
    Asquith, P., Mackintosh, P., Stokes, P. L., Holmes, G. K. T., Cooke, W. T.: Histocompatibility antigens in patients with inflammatory-bowel disease. Lancet 1974 I, 113–115CrossRefGoogle Scholar
  6. 6.
    Behan, P. O., Simpson, J. A., Dick, H.: Immune response genes in myasthenia gravis? Lancet 1973 II, 1033CrossRefGoogle Scholar
  7. 7.
    Benacerraf, B.: The genetic mechanisms that control the immune response and antigen recognition. Ann. d'immunol. Inst. Pasteur 125c, 143–164 (1974)Google Scholar
  8. 8.
    Bertrams, J., Kuwert, E., Liedkte, U.: HL-A antigens and multiple sclerosis. Tissue Antigens 2, 405–408 (1972)CrossRefGoogle Scholar
  9. 9.
    Bertrams, J., Reis, H. E., Kuwert, E., Selmair, H.: Hepatitis associated antigen (HAA), HL-A antigens and auto-lymphocytotoxins (CoCoCy) in chronic aggressive and chronic persistent hepatitis. Z. Immun.-Forsch. 146, 300–307 (1974)Google Scholar
  10. 10.
    Blumenthal, M., Noreen, H., Amos, D. B., Yunis, E.: Genetic mapping of Ir gene in man: linkage with second locus of HL-A. J. Allergy clin. Immunol. 53, 93–94 (1974)Google Scholar
  11. 11.
    Bode, H. H., Dorf, M. E., Forbes, A. P.: Familial lymphocytic thyreoiditis: analysis of linkage with histocompatibility and blood groups. J. clin. Endocr. 37, 692–697 (1973)CrossRefGoogle Scholar
  12. 12.
    Bodmer, W. F.: Evolutionary significance of the HL-A system. Nature (Lond.) 237, 139–145 (1972)CrossRefGoogle Scholar
  13. 13.
    Bodmer, W. F.: Genetic factors in Hodgkin's disease: association with a disease-susceptibility locus (DSA) in the HL-A region. Nat. Cancer Inst. Monogr. 26, 127–134 (1973)Google Scholar
  14. 14.
    Brackertz, D., Mueller-Eckhardt, C., Heinrich, D., Kueppers, F., Schultz, G., Kretschmer, V.: Histocompatibility antigens of patients with rheumatoid arthritis. Z. Immun.-Forsch. 146, 108 (1973)Google Scholar
  15. 15.
    Brewerton, D. A., Caffrey, M., Hart, F. D., James, D. C. O., Nicholls, A., Sturrock, R. D.: Ankylosing spondylitis and HL-A27. Lancet 1973 a II, 904–907CrossRefGoogle Scholar
  16. 16.
    Brewerton, D. A., Caffrey, M., Nicholls, A., Walters, D., James, D. C. O.: Acute anterior uveitis and HL-A27. Lancet 1973 b II, 994–996CrossRefGoogle Scholar
  17. 17.
    Brewerton, D. A., Caffrey, M., Nicholls, A., Walters, D., Oates, J. K., James, D. C. O.: Reiter's disease and HL-A27. Lancet 1973 c II, 996–998Google Scholar
  18. 18.
    Dausset, J.: Correlation between histocompatibility antigens and susceptibility to illness (ed. R. S. Schwartz). Progr. clin. Immunol. 1, 183–210 (1972)Google Scholar
  19. 19.
    Ehlers, N., Kissmeyer-Nielsen, F., Kjerbye, K. E., Lamm, L. U.: HL-A27 in acute and chronic uveitis. Lancet 1974 I, 99CrossRefGoogle Scholar
  20. 20.
    Evans, D. A. P.: Coeliac disease and HL-A8. Lancet 1973 II, 1096Google Scholar
  21. 21.
    Falchuk, Z. M., Rogentine, G. N., Strober, W.: Predominance of histocompatibility antigen HL-A8 in patients with gluten-sensitive enteropathy. J. clin. Invest. 51, 1602–1605 (1972)CrossRefGoogle Scholar
  22. 22.
    Feltkamp, T. E. W., Berg-Loonen, P. M. van der, Nijenhuis, L. E., Engelfriet, C. P., Rossum, A. L. van, Loghem, J. J. van, Oosterhuis, H. J. G. H.: Myasthenia gravis, autoantibodies and HL-A antigens. Brit. med. J. 1974 I, 131–133CrossRefGoogle Scholar
  23. 23.
    Finkelstein, S., Zeller, E., Walford, R. L.: No relation between HL-A and juvenile diabetes. Tissue Antigens 2, 74–77 (1972)CrossRefGoogle Scholar
  24. 24.
    Freudenberg, J., Erdman, K., Meyer zum Buschenfelde, K., Forster, H., Berger, J.: HL-A in liver diseases. Klin. Wschr. 51, 1075 (1973)CrossRefGoogle Scholar
  25. 24a.
    Friis, J., Svejgaard, A.: Salmonella arthritis and HL-A27. Lancet 1974 I, 1350CrossRefGoogle Scholar
  26. 25.
    Fritze, D., Hermann, C., Naeim, F., Smith, G. S., Walford, R. L.: HL-A antigens in myasthenia gravis. Lancet 1974 I, 240–242CrossRefGoogle Scholar
  27. 26.
    Gebhard, R. L., Katz, S. I., Marks, J., Shuster, S., Trapani, R. J., Rogentine, G. N., Strober, W.: HL-A antigen type and small-interstinal disease in dermatitis herpetiformis. Lancet 1973 II, 760–762CrossRefGoogle Scholar
  28. 27.
    Gleeson, M. H., Walker, J. S., Wentzel, J., Chapman, J. A., Harris, R.: Human leukocyte antigens in Crohn's disease and ulcerative colitis. Gut 13, 438–440 (1972)CrossRefGoogle Scholar
  29. 28.
    Grumet, F. C., Coukell, A., Bodmer, J. G., Bodmer, W. F., McDevitt, H. O.: Histocompatibility (HL-A) antigens associated with systemic lupus erythematosus. A possible genetic predisposition to disease. New Engl. J. Med. 285, 193–196 (1971)CrossRefGoogle Scholar
  30. 29.
    Grumet, C., Konishi, J., Payne, R. O., Kris, J. P.: Association of Graves' disease with HL-A8. Clin. Res. 21, 493 (1973)Google Scholar
  31. 30.
    Haldane, J. B. S.: The estimation and significance of the logarithm of a ratio of frequencies. Ann. hum. Genet. 20, 309–311 (1956)CrossRefGoogle Scholar
  32. 31.
    Hedfors, E., Möller, E.: HL-A antigens in sarcoidosis. Tissue Antigens 3, 95–98 (1973)CrossRefGoogle Scholar
  33. 32.
    Histocompatibility Testing 1970 (ed. P. I. Terasaki) pp. 17–44. Copenhagen: Munksgaard 1970Google Scholar
  34. 33.
    Hoot, J. P. van, et al.: Quoted by Evans [20]Google Scholar
  35. 34.
    Jersild, C., Fog, T., Hansen, G. S., Thomsen, M., Svejgaard, A., Dupont, B.: Histocompatibility determinants in multiple sclerosis with special reference to clinical course. Lancet 1973 a II, 1221–1225CrossRefGoogle Scholar
  36. 35.
    Jersild, C., Svejgaard, A., Fog, T., Ammitzbøll, T.: HL-A antigens and diseases. I. Multiple sclerosis. Tissue Antigens 3, 243–250 (1973b)CrossRefGoogle Scholar
  37. 36.
    Jersild, C., Staub Nielsen, L., Ryder, L. P.: UnpublishedGoogle Scholar
  38. 37.
    Katz, S. I., Falchuk, E. M., Dahl, M. V., Rogentine, G. N., Strober, W.: HL-A8: a genetic link between dermatitis herpetiformis and gluten-sensitive enteropathy. J. clin. Invest. 51, 2977–2980 (1972)CrossRefGoogle Scholar
  39. 38.
    Katz, S. I., Dahl, M. V., Penneys, N., Trapani, R. J., Rogentine, N.: HL-A antigens in pemphigus. Arch. Derm. 108, 53–55 (1973)CrossRefGoogle Scholar
  40. 39.
    Kissmeyer-Nielsen, F., Thorsbye, E.: Human transplantation antigens. Transplant. Rev. 4 (1970)Google Scholar
  41. 40.
    Krain, L. S., Terasaki, P. I.: HL-A types in atopic dermatitis. Lancet 1973 I, 1059–1060CrossRefGoogle Scholar
  42. 41.
    Krain, L. S., Terasaki, P. I., Newcomer, V. D., Mickey, M. R.: Increased frequency of HL-A10 in pemphigus vulgaris. Arch. Derm. 108, 803–805 (1973)CrossRefGoogle Scholar
  43. 42.
    Kueppers, F., Mueller-Eckhardt, Ch., Heinrich, D., Schwab, B., Brackertz, D.: HL-A antigens of patients with sarcoidosis. Tissue Antigens 4, 56–58 (1974)CrossRefGoogle Scholar
  44. 43.
    Lamm, L. U., Friedrich, U., Petersen, G. B., Jørgensen, J., Nielsen, J., Therkelsen, A. J., Kissmeyer-Nielsen, F.: Assignment of the major histocompatibility complex to chromosome No. 6 in a family with a pericentric inversion. Hum. Hered. (in press)Google Scholar
  45. 44.
    Lattke, C., Heitmann, H. J., Bertrams, J., Kuwert, E.: Genetische Faktoren bei der Psoriasis vulgaris: Histokompatibilitäts (HL-A)-Antigene. Hautarzt 25, 39 (1974)PubMedGoogle Scholar
  46. 45.
    Levine, B. B., Stember, R. H., Fotino, M.: Ragweed hay fever: genetic control, and linkage to HL-A haplotypes. Science 178, 1201–1203 (1972)CrossRefGoogle Scholar
  47. 46.
    Lewkonia, R. M., Woodrow, J. C., McConnell, R. B., Evans, D. A. P.: HL-A antigens in inflammatory bowel disease. Lancet 1974 I, 574–575Google Scholar
  48. 47.
    Lies, R. B., Messner, R. P., Troup, G. M.: Histocompatibility antigens and RA. Arthr. and Rheum. 15, 524–529 (1972)CrossRefGoogle Scholar
  49. 48.
    Ludwig, H., Polymenidis, Z., Granditsch, G., Wick, G.: Association of HL-A1 and HL-A8 with childhood celiac disease. Z. Immun.-Forsch. 146, 158–167 (1973)Google Scholar
  50. 49.
    Mackay, I. R., Morris, P. J.: Association of autoimmune active chronic hepatitis with HL-A1,8. Lancet 1972 II, 793–795CrossRefGoogle Scholar
  51. 50.
    Marsh, D. G., Bias, W. B., Hsu, S. H., Goodfriend, L.: Association af the HL-A7 crossreacting group with a specific reaginic antibody response in allergic man. Science 179, 691–693 (1973)CrossRefGoogle Scholar
  52. 51.
    McNeish, A. S., Nelson, R., Mackintosh, P.: HL-A1 and 8 in childhood cæliac disease. Lancet 1973 I, 668Google Scholar
  53. 52.
    Miller, R. G.: Simultaneous statistical inference. New York: McGraw-Hill 1966Google Scholar
  54. 52a.
    Morris, P. J., Forbes, J. F.: HL-A in follicular lymphoma, reticulum cell sarcoma, lymphosarcoma and infectious mononucleosis. Transplant. Proc. 3, 1315–1316 (1971)Google Scholar
  55. 53.
    Morris, P. J.: Histocompatibility systems, immune responses and disease in man. Contemporary topics in immunology, Vol. 3. New York-London: Plenum Press (in press)Google Scholar
  56. 54.
    Morris, P. J., Pietsch, M. C.: A possible association between paralytic poliomyelitis and multiple sclerosis. Lancet 1973 II, 847–848CrossRefGoogle Scholar
  57. 55.
    Morris, R., Metzger, A. L., Bluestone, R., Terasaki, P. J.: HL-A W27 — a clue to the diagnosis and pathogenesis of Reiter's syndrome. New Engl. J. Med. 290, 554–555 (1974)CrossRefGoogle Scholar
  58. 56.
    Mourant, A. E., Kopeć, A. C., Domaniewska-Sobczak, K.: Blood-groups and bloodclotting. Lancet 1971 I, 223–228Google Scholar
  59. 57.
    Naito, S., Namerow, N., Mickey, M. R., Terasaki, P. I.: Multiple sclerosis: Association with HL-A3. Tissue Antigens 2, 1–4 (1972)CrossRefGoogle Scholar
  60. 58.
    Nerup, J., Lyngsøe, J., Ortved Andersen, O., Christy, M., Kromann, H., Platz, P., Poulsen, J. E., Ryder, L. P., Staub Nielsen, L., Svejgaard, A., Thomsen, M.: HL-A antigens in diabetes mellitus. Lancet 1974 II, 864–866Google Scholar
  61. 59.
    Nyfors, A., Staub Nielsen, L., Svejgaard, A.: UnpublishedGoogle Scholar
  62. 60.
    Nyulassy, S., Ravingerova, E., Zvarova, E., Buc, M.: HL-A antigens in rheumatoid arthritis. Lancet 1974 I, 450–451CrossRefGoogle Scholar
  63. 61.
    Ohno, S., Aoki, K., Sugiura, S., Nakayama, E., Itakura, K., Aizawa, K.: HL-A5 and Behcet's disease. Lancet 1973 II, 1383–1384CrossRefGoogle Scholar
  64. 62.
    Patel, R., Mickey, M. R., Terasaki, P. I.: Leucocyte antigens and disease. 1. Association of HL-A2 and chronic glomerulonephritis. Brit. med. J. 1969 II, 424–426CrossRefGoogle Scholar
  65. 63.
    Persson, I., Staub Nielsen, L., Svejgaard, A.: UnpublishedGoogle Scholar
  66. 64.
    Pirskanen, R., Tiilikainen, A., Hokkanen, E.: Histocompatibility (HL-A) antigens associated with myasthenia gravis. Ann. clin. res. 4, 304–306 (1972)PubMedGoogle Scholar
  67. 65.
    Platz, P., Dupont, B., Fog, T., Ryder, L. P., Thomsen, M., Svejgaard, A., Jersild, C.: MLC determinants, measles infection and multiple sclerosis. Proc. roy. Soc. Med. (in press, 1974)Google Scholar
  68. 66.
    Platz, P., Donatzky, O.: UnpublishedGoogle Scholar
  69. 67.
    Polymenidis, Z., Ludwig, H., Götz, M.: Cystic fibrosis and HL-A antigens. Lancet 1973 II, 1452CrossRefGoogle Scholar
  70. 68.
    Rachelefsky, G. S., Terasaki, P. I., Katz, R., Stiehm, E. R.: Increased prevalence of W27 in juvenile rheumatoid arthritis. New Engl. J. Med. 290, 892–893 (1974)CrossRefGoogle Scholar
  71. 69.
    Robbins, J. B., Schneerson, R., Argaman, M., Handzel, T.: Hemophilus influenzae type B: Disease and immunity in humans. Ann. intern. Med. 78, 259–269 (1973)CrossRefGoogle Scholar
  72. 70.
    Rosenthal, I., Scholz, S., Klimmek, R., Albert, E. D., Blaha, H.: HL-A antigens and haplotypes in patients with tuberculosis. Z. Immun.-Forsch. 144, 424 (1973)Google Scholar
  73. 71.
    Russell, T. J., Schultes, L. M., Kuban, D. J.: Histocompatibility (HL-A) antigens associated with psoriasis. New Engl. J. Med. 287, 738–739 (1973)CrossRefGoogle Scholar
  74. 72.
    Schlosstein, L., Terasaki, P. I., Bluestone, R., Pearson, C. M.: High association of an HL-A antigen, W27, with ankylosing spondylitis. New Engl. J. Med. 288, 704–706 (1973)CrossRefGoogle Scholar
  75. 73.
    Schoefinius, H.-H., Braun-Falco, O.: Histokompatibilitätsantigene bei Psoriasis. Dtsch. med. Wschr. 99, 440–444 (1974)CrossRefGoogle Scholar
  76. 74.
    Schunter, F., Schieferstein, G.: HL-A-Antigene bei Psoriasis vulgaris. Hautarzt 25, 82–83 (1974)PubMedGoogle Scholar
  77. 75.
    Seignalet, J., Clot, J., Sany, J., Serre, H.: HL-A antigens in rheumatoid arthritis. Vox Sang. (Basel) 23, 468–471 (1972)CrossRefGoogle Scholar
  78. 76.
    Seignalet, J., Clot, J., Guilhou, J. J., Duntze, F., Meynadier, J., Robinet-Levy, M.: HL-A antigens and some immunological parameters in psoriasis. Tissue Antigens 4, 59–68 (1974a)CrossRefGoogle Scholar
  79. 77.
    Seignalet, J., Robinet-Levy, M., Lemaine, J. M.: Les antigenes HL-A chez les porteurs sains de l'antigene Australia. Nouv. Rev. franc. Hémat. 14, 89–104 (1974b)Google Scholar
  80. 78.
    Singal, D. P., Blajchman, M. A.: Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus. Diabetes 22, 429–432 (1973)CrossRefGoogle Scholar
  81. 79.
    Smeraldi, E.: Immunogenetica della sclerosi multipla: Relazione tra antigeni di istocompatibilita'e suscettibilita' alla malattia. Boll. Ist. sieroter. milan. 51, 220–223 (1973)Google Scholar
  82. 80.
    Stokes, P. L., Asquith, P., Holmes, G. K. T., Mackintosh, P., Cooke, W. T.: Inheritance and influence of histocompatibility (HL-A) antigens in adult coeliac disease. Gut 14 627–630 (1973)CrossRefGoogle Scholar
  83. 80a.
    Svejgaard, A.: Iso-antigenic systems of human blood platelets. Series Haematologica, Vol. II, 1969Google Scholar
  84. 81.
    Svejgaard, A.: HL-A and disease. Registration of available data. Tissue Antigens 3, 241–242 (1973)CrossRefGoogle Scholar
  85. 82.
    Svejgaard, A., Jersild, C., Nielsen, L. S., Bodmer, W. F.: HL-A antigens and disease. Statistical and genetical considerations. Tissue Antigens 4, 95–105 (1974a)CrossRefGoogle Scholar
  86. 83.
    Svejgaard, A., Staub Nielsen, L., Svejgaard, E., Kissmeyer-Nielsen, F., Hjortshøj, A., Zachariae, H.: HL-A antigens in psoriasis vulgaris and in pustular psoriasis—population and family studies. Brit. J. Derm. 91, 145–153 (1974b)CrossRefGoogle Scholar
  87. 84.
    Svejgaard, E., Staub Nielsen, L., Svejgaard, A.: UnpublishedGoogle Scholar
  88. 85.
    Säfwenberg, J., Lindblom, J. B., Osterman, P. O.: HL-A frequencies in patients with myasthenia gravis. Tissue Antigens 3, 465–469 (1973)CrossRefGoogle Scholar
  89. 86.
    Thomsen, M., Platz, P., Andersen, Ortved, O., Christy, M., Lyngsøe, J., Nerup, J., Rasmussen, K., Ryder, L. P., Staub Nielsen, L., Svejgaard, A.: MLC typing in juvenile diabetes mellitus and idiopathic Addison's disease. Transplant. Rev. (in press, 1974)Google Scholar
  90. 87.
    Thorsby, E.: The human major histocompatibility system. Transplant. Rev. 18, 51–129 (1974)PubMedGoogle Scholar
  91. 88.
    Thorsby, E., Lie, S. O.: Relationship between the HL-A system and susceptibility to diseases. Transplant. Proc. 3, 1305–1307 (1971)Google Scholar
  92. 89.
    Thorsby, E., Godal, T., Myrvang, B.: HL-A antigens and susceptibility to diseases. II. Leprosy. Tissue Antigens 3, 373–377 (1973)CrossRefGoogle Scholar
  93. 90.
    Vogel, F., Helmbold, W.: Blutgruppen—Populationsgenetik und Statistik. Humangenetik, ein kurzes Handbuch (ed. P. E. Becker), Vol. I (4), pp. 129–557. Stuttgart: Thieme 1972Google Scholar
  94. 91.
    Walford, R. L., Smith, G. S., Waters, H.: Histocompatibility systems and disease states with particular reference to cancer. Transplant. Rev. 7, 78–111 (1971)PubMedGoogle Scholar
  95. 92.
    Waters, H., Konrad, P., Walford, R. L.: The distribution of HL-A histocompatibility factors and genes in patients with systemic lupus erythematosus. Tissue Antigens 1, 68–73 (1971)CrossRefGoogle Scholar
  96. 93.
    Weeke, E., Staub Nielsen, L., Svejgaard, A.: UnpublishedGoogle Scholar
  97. 94.
    White, A. G., Barnetson, R. St. C., DaCosta, J. A. G., McLelland, D. B. L.: The incidence of HL-A antigens in dermatitis herpetiformis. Brit. J. Derm. 89, 133–136 (1973)CrossRefGoogle Scholar
  98. 95.
    White, S. H., Newcomer, V. D., Mickey, M. R., Terasaki, P. I.: Disturbance of HL-A antigen frequency in psoriasis. New Engl. J. Med. 287, 740–743 (1972)CrossRefGoogle Scholar
  99. 96.
    Woodrow, J. C., Treanor, B., Usher, N.: The HL-A system in Reiter's syndrome. Tissue Antigens (in press)Google Scholar
  100. 97.
    Woolf, B.: On estimating the relation between blood group and disease. Ann. hum. Genet. 19, 251–253 (1955)CrossRefGoogle Scholar
  101. 98.
    Zachariae, H., Hjortshøj, A., Kissmeyer-Nielsen, F.: Reiter's disease and HL-A27. Lancet 1973 II, 565–566CrossRefGoogle Scholar
  102. 99.
    Zachariae, H., Hjortshøj, A., Kissmeyer-Nielsen, F., Svejgaard, A., Svejgarad, E., Zachariae, E.: HL-A antigens and psoriatic arthritis. Acta rheum. scand. (in press)Google Scholar

Copyright information

© Springer-Verlag 1974

Authors and Affiliations

  • Lars P. Ryder
    • 1
  • Lillian Staub Nielsen
    • 1
  • Arne Svejgaard
    • 1
  1. 1.Tissue-Typing Laboratory of the Blood-Grouping DepartmentState University Hospital (Rigshospitalet)Copenhagen

Personalised recommendations